Increased prevalence of autoimmune phenomena in myelofibrosis : relationship with clinical and morphological characteristics, and with immunoregulatory cytokine patterns

Autoimmune phenomena and cytokines were investigated in 100 patients with myelofibrosis (MF) and related to marrow fibrosis and clinical risk. Anti-erythrocyte antibodies by mitogen-stimulated direct antiglobulin test (MS-DAT) were positive in 45%, anti-platelets in 15% and organ/non organ-specific in 57% of cases, without clinically overt disease, and mostly in low-risk/intermediate-risk-1 and MF-0/MF-1. TGF-\u3b2 and IL-8 were increased in MS-DAT positive cases, and IFN-\u3b3 in patients with serological autoantibodies. TGF-\u3b2 and IL-17 were elevated in early clinical and morphological stages, while IL-8 increased in advanced stages. These data suggest that autoimmune phenomena and cytokine disregulation are particularly relevant in early MF